argenx NV ADR (ARGX) — the peer cohort
As of 2026-11-10 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.
argenx NV ADR ranks 6 of 7 in its cohort on the Closelooknet composite (63/100) — the cohort is led by Halozyme Therapeutics Inc at 70/100.
| Name | Composite | Momentum | Quality | Valuation | Signal | Off 52w high |
|---|---|---|---|---|---|---|
| ARGX argenx NV ADR | 63 | 79 | 74 | 27 | ok | 9.4% |
| HALO Halozyme Therapeutics Inc | 70 | 76 | 94 | 36 | info | 23.1% |
| ARGX.BR Argen-X | 65 | 85 | 75 | 28 | ok | 6.6% |
| ONC BeOne Medicines AG | 65 | 91 | 64 | 29 | ok | 0.2% |
| REGN Regeneron Pharmaceuticals Inc | 64 | 84 | 72 | 45 | bull | 7.2% |
| UCB.BR UCB SA | 64 | 77 | 71 | 41 | info | 2.2% |
| RIGL Rigel Pharmaceuticals Inc | 60 | 77 | 89 | 73 | info | 16.5% |
Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.
FAQ · from the current data · as of 2026-11-10
Quick answers
Who are argenx NV ADR's peers in the Closelooknet universe?
The cohort is drawn from shared Closelooknet index membership first, then sector: Halozyme Therapeutics Inc (HALO), Argen-X (ARGX.BR), BeOne Medicines AG (ONC), Regeneron Pharmaceuticals Inc (REGN), UCB SA (UCB.BR), Rigel Pharmaceuticals Inc (RIGL), as of 2026-11-10.
How does ARGX score against its peers?
argenx NV ADR's composite reads 63/100, ranking 6 of 7 in its cohort as of 2026-11-10; the cohort's highest composite is Halozyme Therapeutics Inc at 70/100. Closelooknet scores are research diary readings, not ratings or advice.
Mentioned on Closelooknet
Where ARGX appears in the diary — 1 piece, newest first. Every link is our own writing.
Go deeper
Dailies
- A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000
Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG…
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeOne Medicines AGindustry
- REGN Regeneron Pharmaceuticals Incindustry
- UCB.BR UCB SAindustry
- RIGL Rigel Pharmaceuticals Incindustry
- REPL Replimune Group Incindustry
- KOD Kodiak Sciences Incindustry
- XNCR Xencor Incindustry
- VCEL Vericel Corp Ordindustry
- VRDN Viridian Therapeutics Incindustry
- SEPN Septerna, Inc. Common Stockindustry
- MRNA Moderna Incindustry
- MAZE Maze Therapeutics, Inc. Common Stockindustry
- ORKA Oruka Therapeutics, Inc.industry
- ADMA ADMA Biologics Incindustry
- PHARM.AS Pharming Group NVindustry
- MEDCL.PA Medincell SAindustry
- DNA Ginkgo Bioworks Holdingsindustry
- NEU.AU Neuren Pharmaceuticals Ltdindustry